SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________

 

Amendment No. 1 to

FORM 8-K/A

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of report (Date of earliest event reported) August 5, 2011

 

 

VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)

 

 

 

 

Delaware 1-7598 94-2359345
(State or Other Jurisdiction
of Incorporation)		 (Commission File
Number)		 (IRS Employer
 Identification No.)

 

 

3100 Hansen Way, Palo Alto, CA 94304-1030
(Address of Principal Executive Offices) (Zip Code)

 

 

Registrant's telephone number, including area code (650) 493-4000

 

 

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers

On August 5, 2011, Varian Medical Systems, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Filing”) announcing the appointment of David J. Illingworth to the Board of Directors. At the time of the Initial Filing, it had not been determined to which committees Mr. Illingworth would be named. The Company hereby amends the Initial Filing to report that effective February 11, 2012, Mr. Illingworth was appointed to the Audit Committee of the Board of Directors and the Compensation and Management Development Committee of the Board of Directors.

 
 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

 

  Varian Medical Systems, Inc.
   
  By:  /s/ John W. Kuo
  Name:  
Title: 		 John W. Kuo
Corporate Senior Vice President, General Counsel and Secretary

 

Dated: February 15, 2012